Table 2 Medical history of patients with sustained, intermittent and non-PPI users
| Â | Sustained PPI users | Intermittent PPI users | Non-PPI users | p value |
|---|---|---|---|---|
N | 201 | 188 | 249 | Â |
Medicine history | Â | Â | Â | Â |
 Aspirin | 149 (74.1%) | 125 (66.5%) | 170 (68.3%) | 0.221 |
PPI | Â | Â | Â | Â |
 Pantoprazole | 97 (48.2%) | 96 (51.1%) | – | 0.228 |
 Rabeprazole | 9 (4.5%) | 14 (7.4%) | – | 0.399 |
 Lansoprazole | 31 (15.4%) | 18 (9.6%) | – | 0.017 |
 Omeprazole | 7 (3.5%) | 18 (9.6%) | – | 0.041 |
 Esomeprazole | 4 (2.0%) | 17 (9.0%) | – | 0.007 |
 Two or more types | 53 (26.4%) | 25 (13.3%) | – |  < 0.001 |
ACEI/ARB | 140 (69.7%) | 120 (63.8%) | 152 (61.0%) | 0.160 |
CCB | 98 (48.8%) | 78 (41.5%) | 112 (45.0%) | 0.354 |
β blocker | 162 (80.6%) | 133 (70.7%) | 174 (69.9%) | 0.022 |
Statin | 192 (95.5%) | 174 (92.6%) | 223 (89.6%) | 0.061 |
Warfarin | 4 (2.0%) | 1 (0.5%) | 1 (0.4%) | 0.175 |